欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/0778/001
药品名称Cefazolin IPP Pharma 2 g
活性成分
    • Cefazolin 2.0 g
剂型Powder for solution for infusion/injection
上市许可持有人IPP International Pharma Partners GmbH Marienplatz 10-12 D-94081 FÜRSTENZELL Germany
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Romania (RO)
      Cefazolin IPP 2 g pulbere pentru soluţie injectabilă/perfuzabilă
    • Germany (DE)
      Cefazolin IPP 2 g, Pulver zur Herstellung einer Injektions- oder Infusionslösung
    • Denmark (DK)
      Cefazolin IPP
    • United Kingdom (Northern Ireland) (XI)
    • Sweden (SE)
    • Norway (NO)
      Cefazolin IPP
    • Poland (PL)
      Ceftazolin MIP pharma
    • Latvia (LV)
      Cefazolin MIP 2 g pulveris injekciju vai infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Cefazolin MIP 2 g milteliai injekciniam arba infuziniam tirpalui
    • Estonia (EE)
      CEFAZOLIN MIP 2G
    • Hungary (HU)
      CEFAZOLIN IPP 2 g por oldatos injekcióhoz vagy infúzióhoz
许可日期2013/12/19
最近更新日期2025/03/25
药物ATC编码
    • J01DB04 cefazolin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase